Israel’s Bank Hapoalim is offering two new structured products linked respectively to Teva Pharmaceutical Industries, and three Asian stock market indices.The Teva-linked product is an 18-month shekel deposit with a capital guarantee and 100% participation in the rise in Teva's share up to 20%, or 6% if the share rises by more than 20%.

The minimum deposit in the two structured products in ILS1,000 ($275) and the investment deadline is 10 April.